Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - May 2014


Pain Therapeutics

19 May 2014 - 20 May 2014 - London, UK



Bookmark and Share


Assess Alternative Approaches to Animal Models to Minimise the Translational Gap and Accelerate Market Access

Pain Therapeutics 2014 will evaluate the latest regulatory guidelines on pain indications and assess the pricing and reimbursement issues which are faced with generic incursion and patent expiration.

Hear an in-depth analysis of new pain therapeutic targets from bench to bedside and assess the pipeline of novel drugs for unique insights into developments that could restore positive growth in the market.

REASONS TO ATTEND:

  • Discuss and evaluate the latest new therapeutic mechanisms from bench to bedside with key insight from Merck, Spinifiex, Eli Lilly, AbbVie and UCB
  • Hear key presentations from Mundipharma, Nektar and on advances to opioids and strategies to reduce abuse potential
  • Explore the latest in the area of Neuropathic pain for 2014 with the latest case studies from Neuroscience Technologies and GW Pharmaceuticals
  • Evaluate the translation gap with case studies from a pre-clinical and clinical perspective from Karolinska Institutet and OGB Consulting

KEY SPEAKERS:

  • Jordi Serra, CSO, Neuroscience Technologies Ltd
  • Samer Eid, Neuroscience Scientific Knowledge, Merck & Co.
  • Tom McCarthy, Chief Executive Officer and Managing Director, Spinifex Pharmaceuticals
  • Kathleen Kelly, Medical Leader, CNS/Pain, Johnson & Johnson
  • Zara Sands, Computational Medicinal Chemist, UCB
  • Birgit Priest, Senior Scientist, Eli Lilly
  • Philip Kym, Associate Director II, Pain Discovery Research, Abbott Laboratories

Pain Therapeutics has been a premier conference in its field for more than a decade and the 14th instalment will bring together even more key industry experts and leading pioneers to discuss, debate and share ideas and challenges facing the pain management arena. 

Visit http://www.smi-online.co.uk/goto/2014pain-therapeutics3.asp

Alternatively contact John Collins on +44 (0)20 7827 6734 or email jcollins@smi-online.co.uk 




Further information
Scientific News
First Artificial Ribosome Designed
Researchers at the University of Illinois at Chicago and Northwestern University have engineered a tethered ribosome that works nearly as well as the authentic cellular component, or organelle, that produces all the proteins and enzymes within the cell.
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
Sweet Revenge Against Superbugs
A special type of synthetic sugar could be the latest weapon in the fight against superbugs.
Researchers Develop Vaccine that Protects Primates Against Ebola
A collaborative team from The University of Texas Medical Branch at Galveston and the National Institutes of Health have developed an inhalable vaccine that protects primates against Ebola.
Universal Flu Vaccine in the Works
A new study has demonstrated a potential strategy for developing a flu vaccine with potent, broad protection.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Ferring Bets on Bacteriophages to Treat Inflammatory Bowel Disease
Ferring Pharmaceuticals have annoucned that it will collaborate with Intralytix in the latest phase of its early stage development programme for a bacteriophage-based therapy for inflammatory bowel disease (IBD).
A Novel Drug to FIght Malaria
An international team of scientists has announced that a new compound to fight malaria is ready for human trials.
Ebola Vaccine Trial Begins in Senegal
A clinical trial to evaluate an Ebola vaccine has begun in Dakar, Senegal, after initial research started at the Jenner Institute, Oxford University.
New Cell Structure Finding Might Lead to Novel Cancer Therapies
University of Warwick scientists in the U.K. say they have discovered a cell structure which could help researchers understand why some cancers develop.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!